FX Shoulder Solutions, Inc. has received FDA 510(k) clearance for the FX V135® Easytech Shoulder System, the next generation ...
These findings are important because they suggest that more selective JAK inhibition, particularly targeting JAK1 or JAK2, can effectively reduce organ pathology and pathogenic IFN-γ-producing immune ...
Total global net sales -- $196.4 million, representing 3% pro forma constant currency growth for fiscal Q1 2026 (period ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results